Researchers say a widely prescribed medication may offer new hope for glioblastoma patients. A study found that taking gabapentin extended their lives by several months compared to those who didn’t receive the drug. The medication, commonly used to treat nerve pain and seizures, has been shown to improve survival rates in glioblastoma patients. This breakthrough comes as a significant update to current treatment options for this aggressive brain cancer, which affects approximately 12,000 Americans annually and has one of the poorest prognoses in oncology, with most patients dying within 12-14 months after diagnosis.
Source: https://www.bostonglobe.com/2025/05/19/metro/gabapentin-study-glioblastoma-patients